Corticosteroid-exacerbated symptoms in an Andersen's syndrome kindred

Human Molecular Genetics

Volumn 16, Issue 8, 2007, Pages 900-906

  Bendahhou, Saïd ^a   Fournier, Emmanuel ^b   Gallet, Serge ^c   Ménard, Dominique ^d   Larroque, Marie Madeleine ^a   Barhanin, Jacques ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Montluçon Hospital   (France)

^d Rennes University   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ATENOLOL; CORTICOSTEROID; CREATINE KINASE; INWARDLY RECTIFYING POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; POTASSIUM; PREDNISOLONE; TRIPHOSPHOINOSITIDE; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SUBSTITUTION; ANDERSEN SYNDROME; ARTICLE; CASE REPORT; CELL STRAIN COS7; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; DRUG SENSITIVITY; DRUG WITHDRAWAL; ECG ABNORMALITY; ELECTROMYOGRAPHY; EXTRASYSTOLE; FAMILY HISTORY; FATIGUE; FEMALE; GENETIC SCREENING; HEART ARRHYTHMIA; HEART DISEASE; HEART VENTRICLE ARRHYTHMIA; HERPES; HUMAN; HYPOKALEMIC PERIODIC PARALYSIS; LEG PAIN; MALE; MYALGIA; NEUROPATHOLOGY; PERIODIC PARALYSIS; POTASSIUM TRANSPORT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; TACHYCARDIA; URTICARIA; WALKING DIFFICULTY;

ADRENAL CORTEX HORMONES; ADULT; AMINO ACID SEQUENCE; ANDERSEN SYNDROME; ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; ELECTROMYOGRAPHY; FEMALE; GENES, DOMINANT; HUMANS; MALE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PEDIGREE; PHENOTYPE; POTASSIUM CHANNELS, INWARDLY RECTIFYING; SEQUENCE HOMOLOGY, AMINO ACID; TISSUE DISTRIBUTION;

MAMMALIA;

EID: 34447333668     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddm034     Document Type: Article

References (34)

1. Hille, B. (2001) Ionic Channels of Excitable Membranes. Sinauer Associates, Massachusetts.
2. + channels is caused by intracellular spermine. Cell, 80, 149-154.
3. + channel. Nature, 371, 243-246.
4. 2+. J. Gen. Physiol., 26, 109-133.
5. + channels. Science, 266, 1068-1072.
6. Yang, J., Jan, Y.N. and Jan, L.Y. (1995) Determination of the subunit stoichiometry of an inwardly rectifying potassium channel. Neuron, 15, 1441-1447.
7. Plaster, N.M., Tawil, R., Tristani-Firouzi, M., Canun, S., Bendahhou, S., Tsunoda, A., Donaldson, M.R., Iannaccone, S.T., Brunt, E., Barohn, R. et al. (2001) Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell, 105, 511-519.
8. Priori, S.G., Pandit, S.V., Rivolta, I., Berenfeld, O., Ronchetti, E., Dhamoon, A., Napolitano, C., Anumonwo, J., di Barletta, M.R., Gudapakkam, S. et al. (2005) A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ. Res, 96 800-807.
9. Xia, M., Jin, Q., Bendahhou, S., He, Y., Larroque, M.M., Chen, Y., Zhou, Q., Yang, Y., Liu, Y., Liu, B. et al. (2005) A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem. Biophys. Res. Commun., 332, 1012-1019.
10. Ai, T., Fujiwara, Y., Tsuji, K., Otani, H., Nakano, S., Kubo, Y. and Horie, M. (2002) Novel KCNJ2 mutation in familial periodic paralysis with ventricular dysrhythmia. Circulation, 105, 2592-2594.
11. Andelfinger, G., Tapper, A.R., Welch, R.-C., Vanoye, C.G., George, A.L., Jr. and Benson, D.W. (2002) KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes. Am. J. Hum. Genet., 71, 663-668.
12. Tristani-Firouzi, M., Jensen, J.L., Donaldson, M.R., Sansone, V., Meola, G., Hahn, A., Bendahhou, S., Kwiecinski, H., Fidzianska, A., Plaster, N. et al. (2002) Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J. Clin. Invest., 110, 381-388.
13. Donaldson, M.R., Jensen, J.L., Tristani-Firouzi, M., Tawil, R., Bendahhou, S., Suarez, W.A., Cobo, A.M., Poza, J.J., Behr, E., Wagstaff, J. et al. (2003) PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome. Neurology, 60 1811-1816.
14. Hosaka, Y., Hanawa, H., Washizuka, T., Chinushi, M., Yamashita, F., Yoshida, T., Komura, S., Watanabe, H. and Aizawa, Y. (2003) Function, subcellular localization and assembly of a novel mutation of KCNJ2 in Andersen's syndrome. J. Mol. Cell. Cardiol., 35, 409-415.
15. Chun, T.U., Epstein, M.R., Dick, M., II, Andelfinger, G., Ballester, L., Vanoye, C.G., George, A.L., Jr. and Benson, D.W. (2004) Polymorphic ventricular tachycardia and KCNJ2 mutations. Heart Rhythm, 1 235-241.
16. Bendahhou, S., Fournier, E., Sternberg, D., Bassez, G., Furby, A., Sereni, C., Donaldson, M.R., Larroque, M.M., Fontaine, B. and Barhanin, J. (2005) In vivo and in vitro functional characterization of Andersen's syndrome mutations. J. Physiol., 565, 731-741.
17. Davies, N.P., Imbrici, P., Fialho, D., Herd, C., Bilsland, L.G., Weber, A., Mueller, R., Hilton-Jones, D., Ealing, J., Boothman, B.R. et al. (2005) Andersen-Tawil syndrome: New potassium channel mutations and possible phenotypic variation. Neurology, 65, 1083-1089.
18. Ballester, L.Y., Benson, D.W., Wong, B., Law, I.H., Mathews, K.D., Vanoye, C.G. and George, A.L., Jr. (2006) Trafficking-competent and trafficking-defective KCNJ2 mutations in Andersen syndrome. Hum. Mutat., 27, 388.
19. Andersen, E.D., Krasilnikoff, P.A. and Overvad, H. (1971) Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies: a new syndrome? Acta Paediatr. Scand., 60, 559-564.
20. Yoon, G., Oberoi, S., Tristani-Firouzi, M., Etheridge, S.P., Quitania, L., Kramer, J.H., Miller, B.L., Fu, Y.H. and Ptacek, L.J. (2006) Andersen-Tawil syndrome: Prospective cohort analysis and expansion of the phenotype. Am. J. Med. Genet. A, 140, 312-321.
21. Fournier, E. (2004) Electromyography guides towards subgroups of ion channel mutations in periodic paralyses and myotonias. Ann. Neurol. 56, 650-661.
22. Katz, J.S., Wolfe, G.I., Iannaccone, S., Bryan, W.W. and Barohn, R.J. (1999) The exercise test in Andersen syndrome. Arch. Neurol., 56, 352-356.
23. Bendahhou, S., Donaldson, M.R., Plaster, N.M., Tristani-Firouzi, M., Fu, Y.H. and Ptacek, L.J. (2003) Defective potassium channel Kir2.1 trafficking underlies Andersen-Tawil syndrome. J. Biol. Chem., 278, 51779-51785.
24. Sansone, V., Griggs, R.C., Meola, G., Ptacek, L.J., Barohn, R., Iannaccone, S., Bryan, W., Baker, N., Janas, S.J., Scott, W. et al. (1997) Andersen's syndrome: A distinct periodic paralysis. Ann. Neurol., 42, 305-312.
25. Liu, Z., Braverman, L.E. and Malabanan, A. (2006) Thyrotoxic periodic paralysis in a Hispanic man after the administration of prednisone. Endocr. Pract., 12, 427-431.
26. Kaminski, H.J. and Ruff, R.L. (1994) Endocrine myopathies (hyper-and hypo-function of adrenal, thyroid, pituitary, and parathyroid glands) and iatrogenic corticosteroid myopathy. In Engel, A. and Franzini-Armstrong, C. (eds), Myology, McGraw-Hill, New York, pp. 1726-1753.
27. Lopes, C.M., Zhang, H., Rohacs, T., Jin, T., Yang, J. and Logothetis, D.E. (2002) Alterations in conserved Kir channel-PIP(2) interactions underlie channelopathies. Neuron, 34, 933-944.
28. Schulte, U., Hahn, H., Wiesinger, H., Ruppersberg, J.P. and Falder, B. (1998) pH-dependent gating of ROMK (Kirl.1) channels involves conformational changes in both N and C termini. J. Biol. Chem., 273, 34575-34579.
29. Guo, Y., Waldron, G.J. and Murrell-Lagnado, R. (2002) A role for the middle C terminus of G-protein-activated inward rectifier potassium channels in regulating gating. J. Biol. Chem., 277, 48289-48294.
30. Jiang, Y., Lee, A., Chen, J., Cadene, M., Chait, B.T. and MacKinnon, R. (2002) The open pore conformation of potassium channels. Nature, 417, 523-526.
31. Jiang, Y., Lee, A., Chen, J., Cadene, M., Chait, B.T. and MacKinnon, R. (2002) Crystal structure and mechanism of a calcium-gated potassium channel. Nature, 417, 515-522.
32. Garneau, L., Klein, H., Parent, L. and Sauve, R. (2003) Contribution of cytosolic cysteine residues to the gating properties of the Kir2.1 inward rectifier. Biophys. J., 84, 3717-3729.
33. Pegan, S., Arrabit, C., Slesinger, P.A. and Choe, S. (2006) Andersen's syndrome mutation effects on the structure and assembly of the cytoplasmic domains of Kir2.1. Biochemistry, 45, 8599-8606.
34. Hamill, O.P., Marty, A., Neher, E., Sakmann, B. and Sigworth, F.J. (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 391, 85-100.